Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.

Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Abstract Text:

    victor d schepkinVictor D Schepkin,kuei c leeKuei C Lee,kyle kuszpitKyle Kuszpit,mukilan muthuswamiMukilan Muthuswami,timothy d johnsonTimothy D Johnson,thomas l chenevertThomas L Chenevert,alnawaz rehemtullaAlnawaz Rehemtulla,brian d rossBrian D Ross,

    The ultimate goal of any cancer therapy is to target the elimination of neoplastic cells. Although newer therapeutic strategies are in constant development, therapeutic assessment has been hampered by the inability to assess, rapidly and quantitatively, efficacy in vivo. Diffusion imaging and, more recently, sodium MRI have demonstrated their distinct abilities to detect therapy-induced alterations in tumor cellularity, which has been demonstrated to be indicative of therapeutic efficacy. More importantly, both imaging modalities detect tumor response much earlier than traditional methodologies that rely on macroscopic volumetric changes. In this study, the correlation between tumor sodium and diffusion was further tested to demonstrate the sensitivity of sodium imaging to gauge tumor response to therapy by using a 9L rat gliosarcoma treated with varying doses of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea]. This orthotopic model has been demonstrated to display variability in response to BCNU therapy where initial insult has been shown to lead to drug-resistance. In brief, a single 26.6 mg/kg BCNU dose yielded dramatic responses in both diffusion and sodium MRI. However, a second equivalent BCNU dose yielded a much smaller change in diffusion and sodium, suggesting a drop in tumor sensitivity to BCNU. The MRI responses of animals treated with 13.3 mg/kg BCNU were much lower and similar responses were observed after the initial and secondary applications of BCNU. Furthermore, these results were further validated using volumetric measurements of the tumor and also ex vivo determination of tumor sensitivity to BCNU. Overall, these experiments demonstrate the sensitivity and applicability of sodium and diffusion MRI as tools for dynamic assessment of tumor response to therapy.

    Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Publishing Authors By Initials

    vd schepkinVD Schepkin,kc leeKC Lee,k kuszpitK Kuszpit,m muthuswamiM Muthuswami,td johnsonTD Johnson,tl chenevertTL Chenevert,a rehemtullaA Rehemtulla,bd rossBD Ross,

    For similar inorganic chemicals: elements: metals, alkali: sodium research abstracts see: inorganic chemicals: elements: metals, alkali: sodium research

    PUBMED ID PMID:

    MEDLINE DATE:

    Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: NMR in biomedicine

    VOLUME: 19

    Page Numbers: 1035-42

    Journal Abbreviation:

    ISSN: 0952-3480

    DAY: 3

    MONTH: Dec

    YEAR: 2006

    Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8915233

    Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Keywords Mesh Terms:

    KEYWORDS: Sodium

    MESH TERMS: methods

    Chemical & Substance for Abstract: Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. Information

    Substance Name: Sodium

    Registry Number: 7440-23-5

    Grant and Affiliation Information for Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.

    AFFILIATION: National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32310, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCI

    GRANT: R24CA83099

    ACRONYM: CA

    MEDLINETA: NMR Biomed

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News